RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+7.27%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$812M
AUM Growth
+$812M
(-1.3%)
Cap. Flow
-$30.9M
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
40.99%
Holding
68
New
20
Increased
15
Reduced
16
Closed
15
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$35M |
| 2 |
McKesson
MCK
|
$31.5M |
| 3 |
Adverum Biotechnologies
ADVM
|
$21.5M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$20.9M |
| 5 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$18.8M |
Top Sells
| 1 |
Medtronic
MDT
|
$37.6M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$28.8M |
| 3 |
Zimmer Biomet
ZBH
|
$26.6M |
| 4 |
Universal Health Services
UHS
|
$25.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$21M |
Sector Composition
| 1 | Healthcare | 74.09% |
| 2 | Technology | 2.68% |
| 3 | Communication Services | 1.77% |
| 4 | Industrials | 0.7% |
| 5 | Financials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bausch Health
BHC
$2.74B
| $43.6M | 5.04% | 332,567 +104,737 | +46% | +$13.7M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $39.5M | 4.57% | 163,898 -12,800 | -7% | -$3.09M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $35.6M | 4.11% | 784,459 +60,643 | +8% | +$2.75M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $35M | 4.04% | +369,400 | New | +$35M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $34M | 3.92% | 5,706,906 -1,943,362 | -25% | -$11.6M |
|
|
6
McKesson
MCK
$85.4B
| $31.5M | 3.64% | +161,765 | New | +$31.5M |
|
|
CMRX
7
DELISTED
Chimerix, Inc.
CMRX
| $31M | 3.58% | 1,121,032 -216,118 | -16% | -$5.97M |
|
|
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
| $29.8M | 3.44% | 8,342,045 +256,100 | +3% | +$914K |
|
|
RCPT
9
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $27.3M | 3.16% | 439,878 -313,782 | -42% | -$19.5M |
|
|
TRIV
10
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $25.5M | 2.95% | 1,751,518 +210,870 | +14% | +$3.07M |
|
|
RAD
11
DELISTED
Rite Aid Corporation
RAD
| $25.5M | 2.94% | 5,260,710 +2,786,855 | +113% | +$13.5M |
|
12
HCA Healthcare
HCA
$94.5B
| $23.2M | 2.67% | 328,292 -286,767 | -47% | -$20.2M |
|
|
CSLT
13
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $21.8M | 2.52% | 1,683,817 +519,560 | +45% | +$6.72M |
|
|
14
Adverum Biotechnologies
ADVM
$64.6M
| $21.5M | 2.49% | +699,460 | New | +$21.5M |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $20.9M | 2.41% | +231,389 | New | +$20.9M |
|
16
Globus Medical
GMED
$8.27B
| $19M | 2.2% | 966,300 +133,312 | +16% | +$2.62M |
|
|
CBST
17
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $18.8M | 2.17% | +283,756 | New | +$18.8M |
|
|
ZSPH
18
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $18.6M | 2.15% | +474,132 | New | +$18.6M |
|
|
NUVA
19
DELISTED
NuVasive, Inc.
NUVA
| $17.4M | 2.01% | 498,441 -3,850 | -0.8% | -$134K |
|
|
TVTY
20
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $16.4M | 1.9% | 1,026,503 -208,268 | -17% | -$3.34M |
|
|
OXFD
21
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $16.3M | 1.88% | 1,066,415 +105,595 | +11% | +$1.61M |
|
|
NSTG
22
DELISTED
NanoString Technologies, Inc.
NSTG
| $15.9M | 1.84% | 1,453,655 +319,707 | +28% | +$3.5M |
|
|
HNT
23
DELISTED
HEALTH NET INC
HNT
| $15.4M | 1.78% | +334,935 | New | +$15.4M |
|
|
MODN
24
DELISTED
MODEL N, INC.
MODN
| $14.4M | 1.66% | 1,457,278 +96,400 | +7% | +$951K |
|
25
Insmed
INSM
$28.8B
| $14.2M | 1.64% | +1,090,624 | New | +$14.2M |
|